Cellcept (Mycophenolate Mofetil) – Part 3
Cellcept can be used in both adults and children. It can be administered either orally (by mouth) or intravenously (by vein). It is given twice a day and the dose is usually adjusted frequently in the beginning of treatment with the aim of a stable dosing regimen. Generally the dose for cardiac (heart) and hepatic (liver) transplants is higher than that for renal (kidney) transplants.
Generally, Cellcept is not as well tolerated in elderly patients as in younger patients. The elderly are at a higher risk of developing liver, kidney, and heart problems. They are also at risk of developing infections, gastrointestinal bleeding (bleeding from the bowel), and pulmonary edema (fluid overload of the lungs causing breathing difficulty).
Cellcept is not removed by hemodialysis or peritoneal dialysis and supplemental dosing for patients receiving it while on dialysis is not necessary.
Copyright 2007 Insidesurgery.com